PASW (Ping An Biomedical Co) EBIT: $-2.01 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PASW Ping An Biomedical Co Ltd PASW
17 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Ping An Biomedical Co EBIT?

Ping An Biomedical Co PASW -6.49% 17 EBIT is $-2.01 Mil as of Sep. 2025. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Ping An Biomedical Co's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2025 was $-1.52 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ping An Biomedical Co's annualized ROC % for the quarter that ended in Sep. 2025 was -51.16%. Ping An Biomedical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -85.28%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ping An Biomedical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -11.95%.

Ping An Biomedical Co  (NAS:PASW) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ping An Biomedical Co's annualized ROC % for the quarter that ended in Sep. 2025 is calculated as:

ROC % (Q: Sep. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2025 ) + Invested Capital (Q: Sep. 2025 ))/ count )
=-3.112 * ( 1 - 21.47% )/( (1.888 + 7.665)/ 2 )
=-2.4438536/4.7765
=-51.16 %

where

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6.708 - 6.753 - ( 0.015 - max(0, 8.288 - 6.355+0.015))
=1.888

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9.604 - 1.774 - ( 0.165 - max(0, 3.24 - 8.942+0.165))
=7.665

Note: The Operating Income data used here is two times the semi-annual (Sep. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Ping An Biomedical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Sep. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.03/( ( (0.091 + max(-0.857, 0)) + (0.066 + max(6.949, 0)) )/ 2 )
=-3.03/( ( 0.091 + 7.015 )/ 2 )
=-3.03/3.553
=-85.28 %

where Working Capital is:

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.139 + 0.018 + 1.843) - (6.753 + 0.105 + -0.0010000000000012)
=-0.857

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.377 + 0.062 + 6.294) - (1.774 + 0.01 + 4.4408920985006E-16)
=6.949

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ping An Biomedical Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2025 )
=-2.01/16.817
=-11.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ping An Biomedical Co EBIT Related Terms

Ping An Biomedical Co EBIT Historical Data

* Premium members only.

The historical data trend for Ping An Biomedical Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ping An Biomedical Co EBIT Chart

Ping An Biomedical Co Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
EBIT
1.42 1.59 0.24 0.00 -2.02

Ping An Biomedical Co Semi-Annual Data
Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EBIT Get a 7-Day Free Trial Premium Member Only 0.20 0.17 -0.17 -0.50 -1.52

PASW vs DXYN, CULP, UFI: EBIT Comparison

For the Textile Manufacturing subindustry, Ping An Biomedical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ping An Biomedical Co EV-to-EBIT vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ping An Biomedical Co's EV-to-EBIT falls into.


PASW
17GF Score
Ping An Biomedical Co Ltd PASW
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ping An Biomedical Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-2.01 Mil mean?
Ping An Biomedical Co (PASW) has a EBIT of $-2.01 Mil as of Sep. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Ping An Biomedical Co.
Is Ping An Biomedical Co's EBIT too high?
Ping An Biomedical Co's current EBIT is $-2.01 Mil. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's EBIT compare to DXYN and CULP?
Ping An Biomedical Co's EBIT of $-2.01 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Manufacturing - Apparel & Accessories company?
A good EBIT depends on the Manufacturing - Apparel & Accessories industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Ping An Biomedical Co. Ping An Biomedical Co's current EBIT is $-2.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current EBIT of $-2.01 Mil. The current EBIT is $-2.01 Mil. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current EBIT is $-2.01 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ping An Biomedical Co Business Description

Address Tai Nan West Street, 1002-1008, 22nd Floor, China United Plaza, Cheung Sha Wan, Kowloon, Hong Kong, HKG
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score

Get the complete analysis for PASW

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price